Target intelligence / Profile preview

Pancreatic islet alpha cell (Alpha cell)

Target
Alpha cell
Molecular classification
Cell type, Other
01

Overview

Pancreatic islet alpha cells are specialized endocrine cells located within the islets of Langerhans that are primarily responsible for the production and secretion of glucagon [1]. These cells play a fundamental role in glucose counterregulation by stimulating hepatic glucose output through glycogenolysis and gluconeogenesis when blood glucose levels fall [2]. In metabolic disorders such as Type 2 Diabetes, alpha cells often become dysfunctional, leading to inappropriate glucagon secretion that contributes to hyperglycemia [3]. While the alpha cell itself is a cellular component rather than a discrete molecular target like a receptor or enzyme, it is the site of action for several classes of anti-diabetic medications [4]. For instance, GLP-1 receptor agonists and DPP-4 inhibitors work in part by suppressing alpha cell glucagon release in a glucose-dependent manner [4]. Furthermore, current research is investigating the potential to regenerate insulin-producing capacity by triggering the transdifferentiation of alpha cells into beta cells [5]. This cellular plasticity makes the alpha cell a significant focus for future regenerative therapies in Type 1 Diabetes [5].

Other names
Alpha-cellα-cellGlucagon-producing cellPancreatic alpha cellA cell
02

Mechanism of action

Inhibition of glucagon secretion via GLP-1 receptor agonism, somatostatin receptor activation, or paracrine signaling modulation; induction of alpha-to-beta cell transdifferentiation.

03

Biological functions

Glucagon secretionGlucose homeostasisParacrine signalingGlycogenolysis stimulationGluconeogenesis stimulation
04

Disease associations

Type 1 Diabetes MellitusType 2 Diabetes MellitusGlucagonomaHyperglucagonemiaHypoglycemia
05

Safety considerations

Risk of hypoglycemia due to suppressed counterregulatory responsePotential for alpha-cell hyperplasia with chronic glucagon receptor antagonismUnintended consequences of cellular reprogramming
06

Interacting drugs

Exenatide

5 more in the full profile.

07

Biomarkers

Plasma glucagonAristaless-related homeobox (ARX)Proglucagon mRNAGlucagon-like peptide 1 (GLP-1)

Beyond the preview

Go deeper on Pancreatic islet alpha cell (Alpha cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pancreatic islet alpha cell (Alpha cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call